2026 State of Promotional Review: Benchmarks and Insights for Life Sciences

The core benchmarks you expect from our proprietary benchmarks report are all here: workflow duration, review duration, circulations, and days incorporating feedback. What's different is how far you can drill down. For the first time, the report breaks the data out by industry subcohort, region, and market reach so you can compare your team against the organizations most like it.

Find the benchmark that fits your team:

• Biotech, pharma, or medical device? Compare against subcohorts like rare disease, OTC/consumer health, and Class III devices. Across biotech subcohorts alone, median review duration ranges from 5.9 to 12.9 days.
• Reviewing for more than one market? See benchmarks for global/HQ, regional, and country-specific content across North America, LATAM, EMEA, and APAC.
• On the legal, regulatory, or medical team? See how first pass approval and review time differ by reviewer role.
• Chasing down rework? Our new first pass approval metric shows how often content clears review in one circulation (75.7% overall) and what sends the rest back.
• Working out your AI policy? Survey results from real Vodori users on how teams use AI, what worries them, and the guardrails they're putting in place.

Set goals against teams that look like yours, not an industry-wide average.